Specialty code 1835P0018X · San Rafael, CA
NPI
1043483670
Since 2008
Specialty
Specialty code 1835P0018X
Code 1835P0018X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
99 Montecillo Rd
San Rafael, CA, 94903
Phone (415) 492-6505
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$630K
3,481 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Michelle Cunningham prescribed most often to Medicare patients was Atorvastatin Calcium, with 680 prescriptions and refills. In total Michelle Cunningham wrote 3,481 Medicare prescriptions that cost $630K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-04-03.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 680 | 2,259 | 256 | $8,596 |
| Ozempic Semaglutide | 522 | 532 | 83 | $389K |
| Metformin Hcl Er Metformin Hcl | 241 | 802 | 104 | $2,311 |
| Lisinopril Generic | 196 | 651 | 76 | $2,426 |
| Metformin Hcl Generic | 191 | 637 | 77 | $2,818 |
| Rosuvastatin Calcium Generic | 173 | 575 | 66 | $1,964 |
| Losartan Potassium Generic | 151 | 499 | 63 | $2,010 |
| Hydrochlorothiazide Generic | 103 | 343 | 39 | $1,195 |
| Ultra-Fine Nano Pen Needle Pen Needle, Diabetic | 100 | 275 | 42 | $2,032 |
| Amlodipine Besylate Generic | 97 | 323 | 40 | $1,232 |
| Simvastatin Generic | 95 | 317 | 34 | $1,102 |
| Glipizide Generic | 92 | 307 | 36 | $1,302 |
| Jardiance Empagliflozin | 89 | 292 | 31 | $50K |
| Glipizide Er Glipizide | 83 | 276 | 32 | $2,151 |
| Insulin Glargine-Yfgn Generic | 73 | 208 | 38 | $9,258 |
Brand drugs: 971 claims; generic drugs: 2,324 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Michelle Cunningham were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.